Inseal Medical Ltd.
Large-bore access closure devices for the interventionalist
This article was originally published in Start Up
Executive Summary
New minimally invasive interventions for structural heart disease use ever larger devices, creating challenges for transfemoral access site management. While the current state of the art is trying to transform surgical practices into interventional ones, Inseal Medical has a large-bore vascular access closure device that works the way interventional cardiologists do.
You may also be interested in...
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.